StonvexLoading…
StonvexStonvexStonvexCore line items from RSVR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-28 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $45.35M | $128.17M | $82.60M | $37.16M | $158.71M |
Operating Income | Not available | $26.46M | $16.13M | $5.45M | $35.06M |
Net Income | Not available | $3.90M | $1.70M | $-555.66K | $7.75M |
EPS (Diluted) | $0.04 | $0.06 | $0.03 | $-0.01 | $0.12 |
Total Assets | Not available | $941.91M | $903.54M | $856.98M | $865.13M |
Total Liabilities | Not available | $567.10M | $531.42M | $486.87M | $498.93M |
Cash & Equivalents | Not available | $20.59M | $27.94M | $14.86M | $21.39M |
Free Cash Flow OCF − CapEx | Not available | $37.94M | $25.15M | $5.98M | $45.20M |
Shares Outstanding | Not available | 65.59M | 65.59M | 65.49M | 65.24M |